A study to learn BAY 3498264 when given alone or together with sotorasib in participants who have advanced solid cancers with specific genetic changes called KRASG12C mutation

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513300-34-00

Acronym

22676

Enrollment

Registered

2024-10-27

Start date

2024-11-18

Completion date

Unknown

Last updated

2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors harboring KRAS G12C mutation

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026